CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.40% | 7.76% | 8.35% | 6.92% | 3.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.40% | 7.76% | 8.35% | 6.92% | 3.65% |
| Cost of Revenue | 8.63% | 7.48% | 9.60% | 5.69% | 6.10% |
| Gross Profit | 6.83% | 9.71% | 0.90% | 14.61% | -10.76% |
| SG&A Expenses | 9.23% | 3.42% | 1.08% | 4.48% | 1.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.69% | 7.02% | 8.61% | 5.55% | 5.62% |
| Operating Income | -7.19% | 53.48% | 0.22% | 66.51% | -48.23% |
| Income Before Tax | -36.31% | -3,416.19% | -29.53% | 65.63% | -21.40% |
| Income Tax Expenses | -411.93% | 1,394.12% | 11.42% | 83.11% | -23.56% |
| Earnings from Continuing Operations | 80.10% | -5,719.72% | -42.70% | 58.54% | -20.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.76% | -6.25% | 300.00% | 72.73% | 2,200.00% |
| Net Income | 79.01% | -4,668.97% | -42.32% | 59.84% | -19.65% |
| EBIT | -7.19% | 53.48% | 0.22% | 66.51% | -48.23% |
| EBITDA | -4.37% | 29.21% | 0.67% | 42.73% | -35.98% |
| EPS Basic | 77.46% | -4,633.14% | -42.77% | 59.72% | -17.80% |
| Normalized Basic EPS | -19.67% | 61.80% | 2.56% | 76.94% | -39.80% |
| EPS Diluted | 75.32% | -4,633.14% | -43.23% | 60.23% | -17.80% |
| Normalized Diluted EPS | -20.54% | 61.80% | 2.48% | 77.52% | -39.66% |
| Average Basic Shares Outstanding | 0.87% | 0.79% | 0.80% | 0.08% | -2.25% |
| Average Diluted Shares Outstanding | 1.98% | 0.79% | 0.87% | -0.24% | -2.47% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 9.92% |
| Payout Ratio | -0.44% | -1.02% | 0.75% | -0.37% | 0.34% |